Effects of Metabolic Syndrome on Cardiovascular Outcomes of Psoriatic Patients with Coronary Artery Disease: A Single Center Retrospective Cohort Study

References

• Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–2497. doi:10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Lu J, Wang L, Li M, et al. Metabolic syndrome among adults in China: the 2010 China noncommunicable disease surveillance. J Clin Endocrinol Metab. 2017;102(2):507–515. doi:10.1210/jc.2016-2477
   PubMed Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–2716. doi:10.1001/jama.288.21.2709
   PubMed Web of Science ®Google Scholar
• Hess PL, Al-Khalidi HR, Friedman DJ, et al. The metabolic syndrome and risk of sudden cardiac death: the atherosclerosis risk in communities study. J Am Heart Assoc. 2017;6(8). doi:10.1161/JAHA.117.006103
   Web of Science ®Google Scholar
• Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132. doi:10.1016/j.jacc.2010.05.034
   PubMed Web of Science ®Google Scholar
• Ryu J, Yong HS, Huh S, Kang EY, Woo OH. Relation of coronary atherosclerosis and metabolic syndrome in asymptomatic subjects: evaluation with coronary CT angiography. Int J Cardiovasc Imaging. 2013;29(Suppl 2):101–107. doi:10.1007/s10554-013-0319-2
   PubMedGoogle Scholar
• Deo SV, Sundaram V, Wilson B, et al. Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: a 10-year follow-up of the Veterans affairs database. J Thorac Cardiovasc Surg. 2022;163(6):2096–2103.e2093. doi:10.1016/j.jtcvs.2020.08.018
   PubMed Web of Science ®Google Scholar
• Kajimoto K, Kasai T, Miyauchi K, et al. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J. 2008;72(9):1481–1486. doi:10.1253/circj.CJ-07-0928
   PubMed Web of Science ®Google Scholar
• Nigam A, Bourassa MG, Fortier A, Guertin MC, Tardif JC. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J. 2006;151(2):514–521. doi:10.1016/j.ahj.2005.03.050
   PubMed Web of Science ®Google Scholar
• Gisondi P, Bellinato F, Girolomoni G, Albanesi C. Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities. Front Pharmacol. 2020;11:117. doi:10.3389/fphar.2020.00117
   PubMed Web of Science ®Google Scholar
• Diotallevi F, Paolinelli M, Radi G, Offidani A. Latest combination therapies in psoriasis: narrative review of the literature. Dermatol Ther. 2022;35(10):e15759. doi:10.1111/dth.15759
   PubMed Web of Science ®Google Scholar
• Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829–835. doi:10.1016/j.jaad.2006.08.040
   PubMed Web of Science ®Google Scholar
• Trovato E, Rubegni P, Prignano F. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome. Expert Opin Biol Ther. 2022;22(12):1443–1448. doi:10.1080/14712598.2022.2093106
   PubMed Web of Science ®Google Scholar
• Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586–592. doi:10.1111/j.1365-2133.2010.09941.x
   PubMed Web of Science ®Google Scholar
• Zhou J, Liu C, Zhou P, et al. Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome. Nutr Metab Cardiovasc Dis. 2021;31(9):2693–2699. doi:10.1016/j.numecd.2021.05.029
   PubMed Web of Science ®Google Scholar
• Rejas J, Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M. Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study. Schizophr Res. 2008;99(1–3):23–28. doi:10.1016/j.schres.2007.10.015
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–2351. doi:10.1161/CIRCULATIONAHA.106.685313
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Holmannova D, Borsky P, Borska L, et al. Metabolic syndrome, clusterin and elafin in patients with psoriasis vulgaris. Int J Mol Sci. 2020;21(16):5617. doi:10.3390/ijms21165617
   PubMed Web of Science ®Google Scholar
• Liu L, Cai XC, Sun XY, et al. Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence. J Eur Acad Dermatol Venereol. 2022;36(11):1969–1979. doi:10.1111/jdv.18296
   PubMed Web of Science ®Google Scholar
• Adışen E, Uzun S, Erduran F, Gürer MA. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis. An Bras Dermatol. 2018;93(2):205–211. doi:10.1590/abd1806-4841.20186168
   PubMed Web of Science ®Google Scholar
• Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the national health and nutrition examination survey, 2003–2006. Arch Dermatol. 2011;147(4):419–424. doi:10.1001/archdermatol.2010.370
   PubMedGoogle Scholar
• Mebazaa A, El Asmi M, Zidi W, et al. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol. 2011;25(6):705–709. doi:10.1111/j.1468-3083.2010.03856.x
   PubMed Web of Science ®Google Scholar
• Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001;26(1):37–49. doi:10.1016/S0306-4530(00)00035-4
   PubMed Web of Science ®Google Scholar
• Kokpol C, Aekplakorn W, Rajatanavin N. Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study. J Dermatol. 2014;41(10):898–902. doi:10.1111/1346-8138.12614
   PubMed Web of Science ®Google Scholar
• Koku Aksu AE, Saraçoğlu ZN, Metintaş S, Sabuncu İ, Çetin Y. Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: a cross-sectional study in the Turkish population. Anatol J Cardiol. 2017;17(1):66–72. doi:10.14744/AnatolJCardiol.2016.6679
   PubMed Web of Science ®Google Scholar
• Daye M, Temiz SA, Isık B. The relationship between lichen planus and metabolic syndrome. J Cosmet Dermatol. 2021;20(8):2635–2639. doi:10.1111/jocd.13905
   PubMed Web of Science ®Google Scholar
• Luan L, Han S, Wang H, Liu X. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis. Int Immunopharmacol. 2015;29(2):278–284. doi:10.1016/j.intimp.2015.11.005
   PubMed Web of Science ®Google Scholar
• Frieder J, Ryan C. Psoriasis and cardiovascular disorders. G Ital Dermatol Venereol. 2016;151(6):678–693.
   PubMed Web of Science ®Google Scholar
• Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clin Dermatol. 2014;32(3):343–350. doi:10.1016/j.clindermatol.2013.11.001
   PubMed Web of Science ®Google Scholar
• Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005(5):273–279. doi:10.1155/MI.2005.273
   PubMed Web of Science ®Google Scholar
• Ataseven A, Temiz SA, Eren G, Özer İ, Dursun R. Comparison of anti-TNF and IL-inhibitors treatments in patients with psoriasis in terms of response to routine laboratory parameter dynamics. J Dermatolog Treat. 2022;33(2):1091–1096. doi:10.1080/09546634.2020.1801975
   PubMed Web of Science ®Google Scholar
• Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527–1534. doi:10.1001/archderm.141.12.1527
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol. 1996;34(6):1030–1046. doi:10.1016/S0190-9622(96)90284-4
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhu YJ, Zou S, et al. Metabolic syndrome and psoriasis: mechanisms and future directions. Front Immunol. 2021;12:711060. doi:10.3389/fimmu.2021.711060
   PubMed Web of Science ®Google Scholar
• Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s--their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) study. J Am Coll Cardiol. 1996;27(5):1119–1127. doi:10.1016/0735-1097(95)00599-4
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet. 1998;351(9101):478–484. doi:10.1016/S0140-6736(97)11144-8
   PubMed Web of Science ®Google Scholar
• Bauer A, Barthel P, Schneider R, et al. Improved stratification of autonomic regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J. 2009;30(5):576–583. doi:10.1093/eurheartj/ehn540
   PubMed Web of Science ®Google Scholar
• Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007;50(24):2275–2284. doi:10.1016/j.jacc.2007.08.042
   PubMed Web of Science ®Google Scholar
• Gharipour M, Hashemi Jazi M, Nilforoush P, Batvandi A, Mohammadi R, Najafi R. Metabolic syndrome and its association with left ventricular dysfunction in patients with left bundle branch block. Acta Biomed. 2015;86(2):157–161.
   PubMedGoogle Scholar
• Burroughs Peña M, Swett K, Schneiderman N, et al. Cardiac structure and function with and without metabolic syndrome: the Echocardiographic Study of Latinos (Echo-SOL). BMJ Open Diabetes Res Care. 2018;6(1):e000484. doi:10.1136/bmjdrc-2017-000484
   PubMed Web of Science ®Google Scholar
• Chen J, Wang X, Dong B, et al. Cardiac function and exercise capacity in patients with metabolic syndrome: a cross-sectional study. Front Cardiovasrc Med. 2022;9:974802. doi:10.3389/fcvm.2022.974802
   PubMed Web of Science ®Google Scholar
• Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 2003;107(3):499–511. doi:10.1161/01.CIR.0000052939.59093.45
   PubMed Web of Science ®Google Scholar
• Yang X, Luo W, Han S, et al. Prevalence of high-risk coronary plaques in patients with and without metabolic syndrome and the relationship with prognosis. BMC Cardiovasc Disord. 2020;20(1):73. doi:10.1186/s12872-020-01358-8
   PubMed Web of Science ®Google Scholar
• Ramírez-Terán AL, Vega-Memije ME, Torres-Tamayo M, Martínez-Alvarado MR. Carotid intima-media thickness in patients with psoriasis with and without metabolic syndrome. Arch Cardiol Mex. 2022;92(3):305–311. doi:10.24875/ACM.21000106
   PubMed Web of Science ®Google Scholar
• Fan Z, Wang L, Jiang H, Lin Y, Wang Z. Platelet dysfunction and its role in the pathogenesis of psoriasis. Dermatology. 2021;237(1):56–65. doi:10.1159/000505536
   PubMed Web of Science ®Google Scholar
• Zhao L, Meng X, Mei Q, et al. Risk factors for cardiac complications in patients with pheochromocytoma and paraganglioma: a retrospective single-center study. Front Endocrinol. 2022;13:877341. doi:10.3389/fendo.2022.877341
   PubMed Web of Science ®Google Scholar
• Ouviña SM, La Greca RD, Zanaro NL, Palmer L, Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res. 2001;102(2):107–114. doi:10.1016/S0049-3848(01)00237
   PubMed Web of Science ®Google Scholar